
Smith+Nephew is a leading portfolio medical technology company using technology to take the limits off living.
Please note: not all products referred to may be approved for use or available in all markets.
◊ Trademark of Smith+Nephew
Please note: not all products referred to may be approved for use or available in all markets.
◊ Trademark of Smith+Nephew
Location: United Kingdom, England, Holywell
Employees: 10001+
Phone: +44 1923 477100
Founded date: 1856
Investors 1
Date | Name | Website |
- | InterWest ... | interwest.... |
Mentions in press and media 6
Date | Title | Description |
03.02.2014 | Smith & Nephew Buys Austin-based ArthroCare for $1.7 Billion | Smith & Nephew announced Monday a deal to buy ArthroCare Corp. of Austin for $1.7 billion. The London-based company plans to pay $48.25 per share in cash for the the medical device company. “This is a compelling opportunity to add Arthr... |
09.01.2014 | ArthroCare Corp. Pays $30 Million Securities Fraud Fine | ArthroCare Corp., a medical device maker in Austin, has agreed to pay a $30 million fine to settle securities fraud charges. The settlement resolves “charges that senior executives at the company engaged in a securities fraud scheme that re... |
04.07.2013 | Austin-based ArthroCare Corp. Buys ENTrigue Surgical for $45 Million | Fred Dinger has done it again. The San Antonio-based biotechnology entrepreneur sold his startup ENTrigue Surgical for $45 million to ArthroCare Corp. of Austin. Dinger previously sold OsteoBiologics for $72 million to Smith & Nephew En... |
18.06.2012 | How do Wall Street analysts expect the Supreme Court to rule on Obamacare? | People across the healthcare spectrum are waiting with baited breath to hear the U.S. Supreme Court’s verdict on President Barack Obama’s landmark healthcare reform law. Healthcare analysts at Minneapolis investment bank Piper Jaffray in Mi... |
08.09.2011 | ArthroCare gets $8M to settle shareholder suit, denies wrongdoing | ArthroCare Corp. (NSDQ:ATRC) settled a shareholders’ lawsuit by agreeing to an $8 million payment from its insurers, more than a quarter of which will go to the plaintiffs’ lawyers, according to court documents. The Austin, Texas-based surg... |
- | How do Wall Street analysts expect the Supreme Court to rule on Obamacare? | People across the healthcare spectrum are waiting with baited breath to hear the U.S. Supreme Court’s verdict on President Barack Obama’s landmark healthcare reform law. Healthcare analysts at Minneapolis investment bank Piper Jaffray in Mi... |